BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 28449186)

  • 1. The risk of lower gastrointestinal bleeding in low-dose aspirin users.
    Chen WC; Lin KH; Huang YT; Tsai TJ; Sun WC; Chuah SK; Wu DC; Hsu PI
    Aliment Pharmacol Ther; 2017 Jun; 45(12):1542-1550. PubMed ID: 28449186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study.
    Lin CC; Hu HY; Luo JC; Peng YL; Hou MC; Lin HC; Lee FY
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1119-28. PubMed ID: 24099473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based study.
    Peng YL; Hu HY; Luo JC; Hou MC; Lin HC; Lee FY
    Osteoporos Int; 2014 May; 25(5):1617-23. PubMed ID: 24566586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for upper gastrointestinal bleeding among aspirin users: An old issue with new findings from a population-based cohort study.
    Luo PJ; Lin XH; Lin CC; Luo JC; Hu HY; Ting PH; Hou MC
    J Formos Med Assoc; 2019 May; 118(5):939-944. PubMed ID: 30366771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
    Tsai YW; Wen YW; Huang WF; Chen PF; Kuo KN; Hsiao FY
    J Gastroenterol; 2011 Jan; 46(1):39-45. PubMed ID: 20811753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of proton-pump inhibitors on the risk of lower gastrointestinal bleeding associated with NSAIDs, aspirin, clopidogrel, and warfarin.
    Nagata N; Niikura R; Aoki T; Sakurai T; Moriyasu S; Shimbo T; Sekine K; Okubo H; Watanabe K; Yokoi C; Yanase M; Akiyama J; Uemura N
    J Gastroenterol; 2015 Nov; 50(11):1079-86. PubMed ID: 25700638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease.
    Miyake K; Akimoto T; Hanada Y; Nagoya H; Kodaka Y; Ueki N; Kusunoki M; Kawagoe T; Futagami S; Takahashi Y; Takano H; Sakamoto C
    Dig Liver Dis; 2015 Sep; 47(9):757-62. PubMed ID: 26105589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors.
    Venerito M; Schneider C; Costanzo R; Breja R; Röhl FW; Malfertheiner P
    Aliment Pharmacol Ther; 2018 Jun; 47(11):1464-1471. PubMed ID: 29655196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Niro V; Longo MG; D'Ambrosio LP; Andriulli A; Di Mario F
    Aging Clin Exp Res; 2003 Dec; 15(6):494-9. PubMed ID: 14959953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of SSRI, But Not SNRI, Increased Upper and Lower Gastrointestinal Bleeding: A Nationwide Population-Based Cohort Study in Taiwan.
    Cheng YL; Hu HY; Lin XH; Luo JC; Peng YL; Hou MC; Lin HC; Lee FY
    Medicine (Baltimore); 2015 Nov; 94(46):e2022. PubMed ID: 26579809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower GI bleeding risk of nonsteroidal anti-inflammatory drugs and antiplatelet drug use alone and the effect of combined therapy.
    Nagata N; Niikura R; Aoki T; Shimbo T; Kishida Y; Sekine K; Tanaka S; Okubo H; Watanabe K; Sakurai T; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
    Gastrointest Endosc; 2014 Dec; 80(6):1124-31. PubMed ID: 25088922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control study.
    Bakhriansyah M; Souverein PC; de Boer A; Klungel OH
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1141-1148. PubMed ID: 28370857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding.
    Wang Q; Ljung R; Lagergren J; Lu Y
    BMC Pharmacol Toxicol; 2014 Apr; 15():22. PubMed ID: 24731755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of aspirin, NSAIDs, warfarin, corticosteroids and SSRIs on the site and outcome of non-variceal upper and lower gastrointestinal bleeding.
    Ahsberg K; Höglund P; Kim WH; von Holstein CS
    Scand J Gastroenterol; 2010 Dec; 45(12):1404-15. PubMed ID: 20695720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.
    Iwamoto J; Saito Y; Honda A; Matsuzaki Y
    World J Gastroenterol; 2013 Mar; 19(11):1673-82. PubMed ID: 23555156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
    Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
    Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications.
    Zhu LL; Xu LC; Chen Y; Zhou Q; Zeng S
    World J Gastroenterol; 2012 Jun; 18(24):3167-72. PubMed ID: 22791953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations.
    Lanas A; García-Rodríguez LA; Arroyo MT; Gomollón F; Feu F; González-Pérez A; Zapata E; Bástida G; Rodrigo L; Santolaria S; Güell M; de Argila CM; Quintero E; Borda F; Piqué JM;
    Gut; 2006 Dec; 55(12):1731-8. PubMed ID: 16687434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication therapy: Trends of upper and lower gastrointestinal bleeding.
    Guo CG; Zhang F; Wu JT; Cheung KS; Li B; Law SYK; Leung WK
    United European Gastroenterol J; 2021 Jun; 9(5):543-551. PubMed ID: 33956403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.